It's high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer.

Yao, Shiya; Han, Yuejun; Yang, Mengxiang; Jin, Ketao; Lan, Huanrong

Yao, Shiya; Han, Yuejun; Yang, Mengxiang; Jin, Ketao; Lan, Huanrong.

Afiliación

Yao S; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Han Y; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Yang M; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Jin K; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Lan H; Department of Surgical Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China.

Front Immunol ; 14: 1241208, 2023.

Article en En | MEDLINE | ID: mdl-37920463

Asunto(s)

Neoplasias Colorrectales; Inmunoterapia; Humanos; Inmunoterapia/efectos adversos; Inmunoterapia/métodos; Linfocitos T; Neoplasias Colorrectales/tratamiento farmacológico; Microambiente Tumoral

Palabras clave

clinical trial; colorectal cancer; combination therapy; immunogenic cell death; immunotherapy; inducing chemotherapy; tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Inmunoterapia Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google